Neostatin-7 regulates bFGF-induced corneal lymphangiogenesis☆
Abstract
Neostatin-7, with an anti-angiogenic potential, is generated from the proteolytic action of matrix metalloproteinase-7 on collagen XVIII. We previously reported that neostatin-7 inhibited angiogenesis in vitro and in vivo. Here we demonstrate that neostatin-7/collagen XVIII may possess anti-lymphangiogenic activities by: (1) corneal micropellet implantation of neostatin-7 reduced bFGF-induced corneal lymphangiogenesis; (2) neostatin-7 bound to VEGF receptor-3 in vitro; and (3) enhanced corneal lymphangiogenesis and VEGF-C expression in collagen XVIII knockout mice in a corneal wounding model. Understanding the mechanism of neostatin-7/collagen XVIII on corneal lymphangiogenesis may provide therapeutic interventions to treat lymphangiogenesis-related disorders, such as lymphedema, transplantation rejection and cancers.
Keywords: Collagen XVIII, Neostatin-7, Endostatin, Lymphangiogenesis, bFGF
To access this article, please choose from the options below
☆ Supported by EY01792, EY10101 (D.T.A.), NIH EY14048 (J.H.C.), the Illinois Society for the Prevention of Blindness, and Research to Prevent Blindness Grant.
PII: S0014-5793(08)00504-8
doi:10.1016/j.febslet.2008.06.014
© 2008 Federation of European Biochemical Societies. Published by Elsevier BV. All rights reserved.
